BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/28/2026 1:07:49 PM | Browse: 1 | Download: 0
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 122448
DOI 10.4292/wjgpt.122448
Country India
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Emerging antimicrobial peptides in gastrointestinal disorders: Dual role in immunity and therapy
Manuscript Source Invited Manuscript
All Author List Keerthika Selvaraj and Chandrashekaran Girish
Funding Agency and Grant Number
Corresponding Author Chandrashekaran Girish, Professor, Department of Pharmacology, Jawaharlal Institute of Post Graduate Medical Education and Research, JIPMER Campus Road, Gorimedu, Puducherry 605006, Dhanvantari Nagar, India. gcnx2005@gmail.com
Key Words Antimicrobial peptide; Gut microbiota; Antimicrobial resistance; Immunomodulation; Intestinal barrier integrity; Inflammatory bowel disease; Nanotechnology-based delivery; Artificial intelligence in peptide design; Microbiome-targeted therapeutics
Core Tip Antimicrobial peptides (AMPs) represent promising next-generation therapeutics that counter antimicrobial resistance through membrane disruption, immune modulation, and microbiome regulation. Their dual role in host defense and tissue homeostasis- particularly within gastrointestinal environments-underscores their broader physiological significance. Advances in artificial intelligence-driven peptide design and nanotechnology-based delivery systems are progressively addressing pharmacokinetic limitations and enhancing clinical viability. However, challenges including cytotoxicity, proteolytic instability, and high production costs remain. Integrating bioengineering, precision medicine, and microbiome-guided strategies holds considerable potential for establishing AMPs as personalized, clinically translatable anti-infective and immunomodulatory therapeutics.
Citation Selvaraj K, Girish C. Emerging antimicrobial peptides in gastrointestinal disorders: Dual role in immunity and therapy. World J Gastrointest Pharmacol Ther 2026; In press
PDF 122448-in-press.pdf
Received
2026-04-23 06:22
Peer-Review Started
2026-04-23 06:22
First Decision by Editorial Office Director
2026-05-21 08:18
Return for Revision
2026-05-21 08:18
Revised
2026-06-25 04:58
Publication Fee Transferred
Second Decision by Editor
2026-07-27 02:44
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-07-28 13:07
Articles in Press
2026-07-28 13:07
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2150-5349 (online)
Open Access Open-Access: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com